Insider Transactions in Q4 2018 at Cvs Health Corp (CVS)
Insider Transaction List (Q4 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 28
2018
|
Mark T Bertolini Director |
SELL
Bona fide gift
|
Direct |
655,982
-98.5%
|
-
|
|
Dec 20
2018
|
Mark T Bertolini Director |
BUY
Other acquisition or disposition
|
Direct |
522,997
+18.99%
|
$35,040,799
$67.26 P/Share
|
|
Dec 20
2018
|
Mark T Bertolini Director |
SELL
Other acquisition or disposition
|
Indirect |
522,997
-100.0%
|
$35,040,799
$67.26 P/Share
|
|
Dec 02
2018
|
Karen S Lynch President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,060
-14.36%
|
$1,031,740
$79.52 P/Share
|
|
Nov 29
2018
|
David M Denton EVP and CFO |
SELL
Open market or private sale
|
Direct |
25,159
-98.43%
|
$2,012,720
$80.13 P/Share
|
|
Nov 28
2018
|
Karen S Lynch President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
232,359
+30.91%
|
$18,588,720
$80.27 P/Share
|
|
Nov 28
2018
|
Karen S Lynch President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
62,747
+50.0%
|
-
|
|
Nov 28
2018
|
Mark T Bertolini Director |
BUY
Grant, award, or other acquisition
|
Indirect |
623,069
+50.0%
|
-
|
|
Nov 28
2018
|
Mark T Bertolini Director |
BUY
Grant, award, or other acquisition
|
Direct |
142,985
+49.89%
|
$11,438,800
$80.27 P/Share
|
|
Nov 28
2018
|
Roger N Farah Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,821
+44.84%
|
$305,680
$80.27 P/Share
|
|
Nov 28
2018
|
Edward J Ludwig Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,457
+29.98%
|
$996,560
$80.27 P/Share
|
|
Nov 28
2018
|
Fernando Aguirre Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,912
+30.35%
|
$872,960
$80.27 P/Share
|
|
Nov 14
2018
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
14,229
-16.79%
|
$1,166,778
$82.0 P/Share
|
|
Nov 07
2018
|
Richard M Bracken Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,404
+10.97%
|
$109,512
$78.77 P/Share
|
|
Nov 07
2018
|
Alecia A Decoudreaux Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,332
+30.96%
|
$103,896
$78.77 P/Share
|
|
Nov 07
2018
|
Nancy Ann Deparle Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,332
+9.71%
|
$103,896
$78.77 P/Share
|
|
Nov 07
2018
|
David W Dorman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,618
+3.11%
|
$282,204
$78.77 P/Share
|
|
Nov 07
2018
|
Anne A. Finucane Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,332
+50.0%
|
$103,896
$78.77 P/Share
|
|
Nov 07
2018
|
Jean Pierre Millon Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,332
+50.0%
|
$103,896
$78.77 P/Share
|
|
Nov 07
2018
|
Tony L White Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,332
+4.62%
|
$103,896
$78.77 P/Share
|
|
Oct 01
2018
|
Lisa Bisaccia Former EVP & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
21,534
-33.21%
|
$1,722,720
$80.0 P/Share
|
|
Oct 01
2018
|
Lisa Bisaccia Former EVP & Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,534
+24.76%
|
$1,055,166
$49.8 P/Share
|
|
Oct 01
2018
|
Eva C Boratto EVP & CFO |
SELL
Open market or private sale
|
Direct |
4,426
-9.56%
|
$354,080
$80.0 P/Share
|
|
Oct 01
2018
|
Eva C Boratto EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,426
+8.73%
|
$239,004
$54.53 P/Share
|